vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Clarus Corp (CLAR). Click either name above to swap in a different company.
Clarus Corp is the larger business by last-quarter revenue ($65.4M vs $44.9M, roughly 1.5× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -47.8%, a 27.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -8.4%). Clarus Corp produced more free cash flow last quarter ($11.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -2.9%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
ABCL vs CLAR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $65.4M |
| Net Profit | $-8.9M | $-31.3M |
| Gross Margin | — | 27.7% |
| Operating Margin | -63.7% | -59.6% |
| Net Margin | -19.9% | -47.8% |
| Revenue YoY | 788.4% | -8.4% |
| Net Profit YoY | 73.9% | 52.3% |
| EPS (diluted) | $-0.03 | $-0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $65.4M | ||
| Q3 25 | $9.0M | $69.3M | ||
| Q2 25 | $17.1M | $55.2M | ||
| Q1 25 | $4.2M | $60.4M | ||
| Q4 24 | $5.0M | $71.4M | ||
| Q3 24 | $6.5M | $67.1M | ||
| Q2 24 | $7.3M | $56.5M | ||
| Q1 24 | $10.0M | $69.3M |
| Q4 25 | $-8.9M | $-31.3M | ||
| Q3 25 | $-57.1M | $-1.6M | ||
| Q2 25 | $-34.7M | $-8.4M | ||
| Q1 25 | $-45.6M | $-5.2M | ||
| Q4 24 | — | $-65.5M | ||
| Q3 24 | $-51.1M | $-3.2M | ||
| Q2 24 | $-36.9M | $-5.5M | ||
| Q1 24 | $-40.6M | $21.9M |
| Q4 25 | — | 27.7% | ||
| Q3 25 | — | 35.1% | ||
| Q2 25 | — | 35.6% | ||
| Q1 25 | — | 34.4% | ||
| Q4 24 | — | 33.4% | ||
| Q3 24 | — | 35.0% | ||
| Q2 24 | — | 36.1% | ||
| Q1 24 | — | 35.9% |
| Q4 25 | -63.7% | -59.6% | ||
| Q3 25 | -851.8% | -4.4% | ||
| Q2 25 | -290.2% | -19.7% | ||
| Q1 25 | -1479.6% | -11.2% | ||
| Q4 24 | — | -70.2% | ||
| Q3 24 | -1439.4% | -8.0% | ||
| Q2 24 | -1276.2% | -14.4% | ||
| Q1 24 | -551.5% | -9.8% |
| Q4 25 | -19.9% | -47.8% | ||
| Q3 25 | -637.8% | -2.3% | ||
| Q2 25 | -203.3% | -15.3% | ||
| Q1 25 | -1077.2% | -8.7% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | -785.4% | -4.7% | ||
| Q2 24 | -504.3% | -9.7% | ||
| Q1 24 | -408.0% | 31.6% |
| Q4 25 | $-0.03 | $-0.81 | ||
| Q3 25 | $-0.19 | $-0.04 | ||
| Q2 25 | $-0.12 | $-0.22 | ||
| Q1 25 | $-0.15 | $-0.14 | ||
| Q4 24 | — | $-1.72 | ||
| Q3 24 | $-0.17 | $-0.08 | ||
| Q2 24 | $-0.13 | $-0.14 | ||
| Q1 24 | $-0.14 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $36.7M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $966.9M | $196.4M |
| Total Assets | $1.4B | $249.0M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $36.7M | ||
| Q3 25 | $83.2M | $29.5M | ||
| Q2 25 | $92.4M | $28.5M | ||
| Q1 25 | $159.3M | $41.3M | ||
| Q4 24 | $156.3M | $45.4M | ||
| Q3 24 | $126.6M | $36.4M | ||
| Q2 24 | $148.3M | $46.2M | ||
| Q1 24 | $123.6M | $47.5M |
| Q4 25 | — | $0 | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $37.0K |
| Q4 25 | $966.9M | $196.4M | ||
| Q3 25 | $964.0M | $225.8M | ||
| Q2 25 | $1.0B | $225.1M | ||
| Q1 25 | $1.0B | $229.3M | ||
| Q4 24 | $1.1B | $233.1M | ||
| Q3 24 | $1.1B | $308.5M | ||
| Q2 24 | $1.1B | $307.3M | ||
| Q1 24 | $1.1B | $310.4M |
| Q4 25 | $1.4B | $249.0M | ||
| Q3 25 | $1.4B | $283.1M | ||
| Q2 25 | $1.4B | $286.5M | ||
| Q1 25 | $1.3B | $292.8M | ||
| Q4 24 | $1.4B | $294.1M | ||
| Q3 24 | $1.4B | $375.3M | ||
| Q2 24 | $1.4B | $369.4M | ||
| Q1 24 | $1.5B | $377.0M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $12.5M |
| Free Cash FlowOCF − Capex | $-44.6M | $11.6M |
| FCF MarginFCF / Revenue | -99.4% | 17.7% |
| Capex IntensityCapex / Revenue | 21.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $12.5M | ||
| Q3 25 | $-52.6M | $-5.7M | ||
| Q2 25 | $-32.4M | $-9.4M | ||
| Q1 25 | $-11.6M | $-2.1M | ||
| Q4 24 | $-108.6M | $16.6M | ||
| Q3 24 | $-28.9M | $-8.3M | ||
| Q2 24 | $-30.0M | $834.0K | ||
| Q1 24 | $-41.7M | $-16.4M |
| Q4 25 | $-44.6M | $11.6M | ||
| Q3 25 | $-61.5M | $-7.0M | ||
| Q2 25 | $-45.8M | $-11.3M | ||
| Q1 25 | $-22.2M | $-3.3M | ||
| Q4 24 | $-187.0M | $14.4M | ||
| Q3 24 | $-47.4M | $-9.4M | ||
| Q2 24 | $-50.1M | $-744.0K | ||
| Q1 24 | $-65.8M | $-18.3M |
| Q4 25 | -99.4% | 17.7% | ||
| Q3 25 | -687.0% | -10.0% | ||
| Q2 25 | -267.9% | -20.4% | ||
| Q1 25 | -524.0% | -5.4% | ||
| Q4 24 | -3702.8% | 20.1% | ||
| Q3 24 | -728.4% | -14.0% | ||
| Q2 24 | -683.8% | -1.3% | ||
| Q1 24 | -661.5% | -26.3% |
| Q4 25 | 21.9% | 1.4% | ||
| Q3 25 | 99.7% | 1.8% | ||
| Q2 25 | 78.2% | 3.4% | ||
| Q1 25 | 251.1% | 2.0% | ||
| Q4 24 | 1552.7% | 3.1% | ||
| Q3 24 | 284.6% | 1.6% | ||
| Q2 24 | 274.6% | 2.8% | ||
| Q1 24 | 242.5% | 2.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
